What Are Whales Doing With Pfizer A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 29 strange trades. Benzinga · Feb 28, 2022
Drugmakers Reap Billions Meeting Covid-19 Needs Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable. Bangkok Post · Feb 27, 2022
Covid vaccines for children: how many doses are needed and what happens if they’ve been infected or are under five? Making sure adults and older children are vaccinated, as well as mask wearing and social distancing, is the best thing to do if worried about under-fives not being eligible, expert says The Guardian - AU · Feb 26, 2022
Q&A: Why the CDC suggests more time between 1st and 2nd COVID vaccine doses for some people LOS ANGELES — After recommending for more than a year that people wait only a few weeks between their first and second doses of COVID-19 vaccines, the U.S. Centers for Disease Control and Prevention has adjusted its suggested timeline for some people by another month or so. Los Angeles Times · Feb 26, 2022
Longer Waiting Period Between mRNA COVID-19 Doses May Cut Heart Inflammation Risk, CDC Suggests The Centers for Disease Control and Prevention said that younger males should consider waiting longer between doses of Pfizer Inc's (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) and Moderna Benzinga · Feb 25, 2022
Pan corona vax in the works: mRNA scientist Drew Weissman HYDERABAD: At a time when there are fears of the emergence of new Covid-19 variants, American physician-scientist Dr Drew Weissman, who along with Dr Katalin Kariko worked on the mRNA vaccine platform that enabled Pfizer and Moderna to develop Covid-19 vaccines, said his lab was now working on a pan… The Times of India · Feb 24, 2022
Pfizer Whale Trades Spotted A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 45 strange trades. Benzinga · Feb 24, 2022
Pfizer's Cannabinoid-Related Biotech Company Arena's Q4 Net Loss Grows 27% YoY Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) revealed Wednesday financial results for the fourth quarter and full year ended Dec. 31, 2021. Q4 Finanical HIghlights Benzinga · Feb 24, 2022
Will you need a 2nd booster shot to keep coronavirus at bay? With omicron fading and pressure growing to ease mask rules and other pandemic restrictions, there is growing debate among health officials and experts about if or when a second booster shot will be part of this path toward recovery. Los Angeles Times · Feb 24, 2022
CDC: Some people should wait longer for 2nd COVID shot U.S. health officials say some people getting Pfizer or Moderna COVID-19 vaccines should consider waiting up to eight weeks between the first and second doses The Independent UK · Feb 23, 2022
Covid live: Poland, Slovakia and Iceland latest countries set to end most coronavirus restrictions — as it happened Move comes as case numbers and deaths continue to fall in many nations The Guardian - UK · Feb 23, 2022
The Moderna vaccine is now available for 6 to 11 year olds. Here's what parents need to know Australian children aged six to 11 years old will be able to get the Moderna COVID vaccine at pharmacies, GP clinics and vaccination hubs from tomorrow. The Conversation · Feb 23, 2022
S. Korea approves Pfizer's COVID vaccine for ages 5-11 South Korean health officials have approved Pfizer’s COVID-19 vaccine for children aged 5 to 11, expanding the country's immunization program in the face of a massive omicron outbreak that is driving up hospitalizations and deaths The Independent UK · Feb 23, 2022
Moderna COVID-19 vaccine approved for six- to 11-year-old children Children aged six to 11 years can get a Moderna COVID-19 vaccine from tomorrow, after it was given the final green light. ABC News · Feb 22, 2022
The Conversation · Feb 22, 2022 Do COVID boosters cause more or fewer side effects? How quickly does protection wane? Your questions answered The Australian Technical Advisory Group on Immunisation (ATAGI) recommends Australians aged 16 years and older have a COVID booster vaccine three months after receiving their second dose.
Tribune News Service · Feb 21, 2022 Mayo Clinic expert stresses importance of vaccinating school-age children for COVID-19 Parents hoping to get their young children vaccinated for COVID-19 will have to wait at least another two months. The Food and Drug Administration (FDA) recently postponed a decision on an emergency use authorization of the Pfizer vaccine for kids 6 months to 4 years old. The FDA is waiting…
The Guardian - UK · Feb 21, 2022 Germany to begin rollout of Novavax’s jab; New Zealand to end vaccine mandates after Omicron peak Latest updates: Germany hopes protein-based vaccine comparable to flu jabs will help sway people sceptical of mRNA vaccines
Asharq Al-Awsat · Feb 20, 2022 Egypt to Receive New Batches of Pfizer Covid Vaccines Health Ministry Spokesman Hossam Abdel Ghaffar said Egypt is set to receive a new shipment containing 2,158,650 doses of the Pfizer coronavirus vaccine. In statements to the MENA news agency on Saturday, the spokesman added that the shipment is part of the state’s plan to provide various kinds of vaccines…
Ballotpedia · Feb 19, 2022 The Federal Tap: Congressman Jim Hagedorn (R) passes away Our weekly summary of federal news updates you on Congressman Jim Hagedorn’s (R) recent death and the newest congressional districts in Minnesota. Read all about it in this week’s edition of the Federal Tap.
Bangkok Post · Feb 19, 2022 Vaccine side effects very rare, says DDC Few side effects have been reported among the 120 million Covid-19 vaccine doses administered, according to the Department of Disease Control (DDC).
The Guardian - UK · Feb 18, 2022 Covid: South Korea reports more than 100,000 new cases for first time – as it happened Latest updates: south Korean case numbers have risen in recent weeks due to Omicron
Caixin Global · Feb 18, 2022 Opinion: China Has Approved Pfizer’s Covid Drug. What’s Next? The government now needs to place an order and set a delivery schedule, given the limited supply
McClatchy Washington Bureau · Feb 18, 2022 FDA says official suggesting annual COVID vaccines ‘does not work on vaccine matters’ A video has emerged of a Food and Drug Administration executive suggesting there are plans for annual COVID-19 vaccines to be implemented in the United States.
Benzinga · Feb 17, 2022 Pfizer/BioNTech's Omicron-Targeted COVID-19 To Miss March Timeline: Reuters Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) omicron-targeted COVID-19 vaccine is delayed by several weeks due to a slower-than-expected data gathering process,
Daily Mirror · Feb 17, 2022 Can my child have the Covid vaccine – and what are the side effects? The Covid vaccine programme has been extended further to include children aged five to 11 without underlying health conditions, in a bid to protect against potential future waves of Covid-19